Pharmaceutical firm wins development grant

New Mexico Business Weekly – April 26, 2006
Maas BioIAB LLC has received a $50,000 grant to continue development of its cyclosporin neuroprotection products.

Maas is a pharmaceutical firm based in Albuquerque. The funds came from the Fort Detrick Technology Transfer Initiative, managed by the Maryland Technology Development Corp. Maas is developing proprietary cyclosporin formulations for the treatment of battlefield traumatic brain injury and nerve agent exposure, which are being tested at the Walter Reed Army Institute of Research in Silver Spring, Md.



Do I Have a Case?

If you’d like to speak with an attorney, fill out the form below or call us at (415) 688-2176

    • Please enter your name.
    • Please enter your phone number.
      This isn't a valid phone number.
    • This isn't a valid email address.
      Please enter your email address.
    • Please make a selection.
    • Please enter a message.